Krognes Steve E.
CIK: 0001666236
Primary company: Guardant Health, Inc. (GH)
Krognes Steve E. is a corporate insider at Guardant Health, Inc. (GH) filing SEC Form 4 transactions. 173 transactions across 5 companies, totaling $0 in purchases and $15,192,415 in sales. Source: SEC EDGAR.
AI Insider Summary
Steve Krognes runs a two-directional biotech-board record: a Guardant Health (GH) sale of 9,294 shares at $132.51, set against Denali Therapeutics (DNLI) awards of 19,226 and 6,408 shares near $19.66. A small Corvus (CRVS) tie completes a multi-company director profile.
Analysis generated by 13F Insight from SEC Form 4 filing data. Methodology
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Sale | 971 | $177.48 | $172K | 7,906 | 9/16/2026 Filed: 9/16/2026 | Filing → | |
| Sale | 1,300 | $176.34 | $229K | 8,877 | 9/16/2026 Filed: 9/16/2026 | Filing → | |
| Sale | 3,300 | $175.42 | $579K | 10,177 | 9/16/2026 Filed: 9/16/2026 | Filing → | |
| Sale | 1,103 | $174.46 | $192K | 13,477 | 9/16/2026 Filed: 9/16/2026 | Filing → | |
| Exercise | 155 | - | - | 0 | 6/30/2026 Filed: 6/30/2026 | Filing → | |
| Exercise | 155 | - | - | 14,580 | 6/30/2026 Filed: 6/30/2026 | Filing → | |
| Award | 2,711 | - | - | 2,711 | 6/17/2026 Filed: 6/17/2026 | Filing → | |
| Exercise | 4,203 | - | - | 0 | 6/17/2026 Filed: 6/17/2026 | Filing → | |
| Exercise | 4,203 | - | - | 14,425 | 6/17/2026 Filed: 6/17/2026 | Filing → | |
| Sale | 9,294 | $132.51 | $1.23M | 10,222 | 6/4/2026 Filed: 6/4/2026 | Filing → | |
| Award | 19,226 | $19.66 | $378K | 19,226 | 6/3/2026 Filed: 6/3/2026 | Filing → | |
| Award | 6,408 | - | - | 38,202 | 6/3/2026 Filed: 6/3/2026 | Filing → | |
| Exercise | 154 | - | - | 155 | 5/31/2026 Filed: 5/31/2026 | Filing → | |
| Exercise | 154 | - | - | 19,516 | 5/31/2026 Filed: 5/31/2026 | Filing → | |
| Exercise | 154 | - | - | 309 | 4/30/2026 Filed: 4/30/2026 | Filing → | |
| Exercise | 154 | - | - | 19,362 | 4/30/2026 Filed: 4/30/2026 | Filing → | |
| Exercise | 155 | - | - | 463 | 3/31/2026 Filed: 4/1/2026 | Filing → | |
| Exercise | 155 | - | - | 19,208 | 3/31/2026 Filed: 4/1/2026 | Filing → | |
| Exercise | 154 | - | - | 618 | 2/28/2026 Filed: 2/28/2026 | Filing → | |
| Exercise | 154 | - | - | 19,053 | 2/28/2026 Filed: 2/28/2026 | Filing → |
Type
Sale
Shares
971
Price
$177.48
Value
$172K
Type
Sale
Shares
1,300
Price
$176.34
Value
$229K
Type
Sale
Shares
3,300
Price
$175.42
Value
$579K
Type
Sale
Shares
1,103
Price
$174.46
Value
$192K
Type
Exercise
Shares
155
Price
-
Value
-
Type
Exercise
Shares
155
Price
-
Value
-
Type
Award
Shares
2,711
Price
-
Value
-
Type
Exercise
Shares
4,203
Price
-
Value
-
Type
Exercise
Shares
4,203
Price
-
Value
-
Type
Sale
Shares
9,294
Price
$132.51
Value
$1.23M
Type
Award
Shares
19,226
Price
$19.66
Value
$378K
Type
Award
Shares
6,408
Price
-
Value
-
Type
Exercise
Shares
154
Price
-
Value
-
Type
Exercise
Shares
154
Price
-
Value
-
Type
Exercise
Shares
154
Price
-
Value
-
Type
Exercise
Shares
154
Price
-
Value
-
Type
Exercise
Shares
155
Price
-
Value
-
Type
Exercise
Shares
155
Price
-
Value
-
Type
Exercise
Shares
154
Price
-
Value
-
Type
Exercise
Shares
154
Price
-
Value
-
AI Agent
Try asking...